TY  - JOUR
AU  - Arjona-Sanchez, Alvaro
AU  - Rufian-Peña, Sebastian
AU  - Artiles, Manuel
AU  - Sanchez-Hidalgo, Juan Manuel
AU  - Casado-Adam, Angela
AU  - Cosano, Antonio
AU  - Thoelecke, Heather
AU  - Ramnarine, Sharmila
AU  - Garcilazo, Dimas
AU  - Briceño-Delgado, Javier
PY  - 2018
DO  - 10.1080/02656736.2018.1423708
UR  - http://hdl.handle.net/10668/11967
T2  - International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
AB  - The cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has showed promising results for the survival in patients with recurrent ovarian carcinomatosis, however, some of them will recur within the first year. The aim of...
LA  - en
PB  - Taylor & Francis
KW  - HIPEC
KW  - Ovarian cancer
KW  - Peritonectomy
KW  - Adult
KW  - Aged
KW  - Chemotherapy adjuvant
KW  - Cytoreduction surgical procedures
KW  - Female
KW  - Humans
KW  - Hyperthermia, induced
KW  - Male
KW  - Middle aged
KW  - Neoplasm recurrence, local
KW  - Ovarian neoplasms
KW  - Peritoneal neoplasms
KW  - Prospective studies
KW  - Recurrence
KW  - Retrospective studies
KW  - Risk factors
KW  - Survival analysis
TI  - Residual tumour less than 0.25 centimetres and positive lymph nodes are risk factors for early relapse in recurrent ovarian peritoneal carcinomatosis treated with cytoreductive surgery, HIPEC and systemic chemotherapy.
TY  - research article
VL  - 34
ER  -